Interpretation of pulmonary function tests (specifically, spirometry) need not be difficult! We will review interpretation and performance of spirometry in a way that makes you comfortable with testing and its utility. This breathing test helps in the evaluation of many different respiratory symptoms and diseases. It is used to distinguish normal from abnormal lung function, identify patterns of airflow obstruction vs patterns of restriction (small volumes), quantify the severity of abnormalities, and test for reversibility of obstructive abnormalities. We will also touch on the pitfalls that can lead to inadequate testing and thereby misinterpretation of test results.
This presentation will provide a pulmonologist’s “curbside consult” on three common topics in pulmonary medicine: treating a patient with chronic cough, managing with a patient with a positive PPD skin test, and following up after the finding of a solitary pulmonary nodule on chest imaging. The first section will emphasize the differential diagnoses for chronic cough besides asthma, such as post-nasal drip, gastroesophageal reflux, and angiotensin converting enzyme inhibitor-associated cough. The second section will address who should be tested for latent tuberculosis, how best to test, and optimal patient selection for TB chemoprophylaxis. In the third section, we will consider annual screening for lung cancer in active and former smokers, and how to manage an incidentally found solitary lung nodule.
This talk will focus on several pulmonary topics that often arise in the primary care setting. I have chosen these topics based on scenarios that are common and confusing. For instance, I will review my approach to patients who come to clinic with a diagnosis of asthma for whom the clinical suspicion is low including spirometry and methacholine challenge interpretation. Next, we will review the evidence for using long term oxygen therapy in respiratory patients including the various oxygen delivery systems. I will also cover the approach to chronic cough when the typical therapies have failed to improve symptoms. I will finish with the current evidence and approach to lung cancer screening. If time remains we will answers additional questions from the audience.
The FDA has not approved any ENDS product as an effective or safe smoking cessation tool. Earlier evidence did not indicate that ENDS were effective or sustainable. Most of these studies were done on earlier prototypes of e-cigarettes. A recent study from the UK found that newer generation ENDS were more successful than approved NRT products for smoking cessation. Join us as we discuss this new evidence and how it impacts strategies to assist with smoking cessation.
Help your patients breathe easier with practical takeaways from this session on the individualized management of asthma. You will learn to diagnose and assess asthma severity and how to implement a stepwise approach to treatment based on that severity as well as asthma subtype, phenotype or endotype, and any underlying comorbidities. Self-management strategies from faculty experts and a proper inhaler technique demonstration will empower you to make a difference in the lives of your patients with asthma.
Patients with COPD frequently have exacerbations, often triggered by an acute upper respiratory infection (URI). C-reactive protein (CRP) testing is a new way of assessing whether or not antibiotics are needed to treat.
Confused about new treatments for asthma? Wondering if your patient even has asthma? In this talk, you will learn to be confident in your diagnosis of asthma and recognize if it is well controlled or out of control. The faculty will discuss how to fit new treatments into the guidelines-based stepped treatment scheme and select among the many choices at each level.